FCPM III SERVICES B.V. Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$592.4B
Holdings
8
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (8 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,597,181 | $272.3B | 45.97% | |
| 2 | DYNDYNE THERAPEUTICS INC | 5,462,846 | $128.7B | 21.73% | |
| 3 | ENGNENGENE HOLDINGS INC | 9,632,561 | $64.1B | 10.81% | |
| 4 | BCYCBICYCLE THERAPEUTICS PLC | 3,452,330 | $48.3B | 8.16% | |
| 5 | REPLREPLIMUNE GROUP INC | 3,970,668 | $48.1B | 8.12% | |
| 6 | CATBUSDASTRIA THERAPEUTICS INC | 2,872,537 | $25.7B | 4.34% | |
| 7 | 698ACHILLES THERAPEUTICS PLC | 2,390,050 | $2.7B | 0.46% | |
| 8 | ENGNWENGENE HOLDINGS INC | 2,878,148 | $2.4B | 0.41% |